Literature DB >> 21858822

Biophysical characterization and conformational stability of Ebola and Marburg virus-like particles.

Lei Hu1, Jared M Trefethen, Yuhong Zeng, Luisa Yee, Satoshi Ohtake, David Lechuga-Ballesteros, Kelly L Warfield, M Javad Aman, Sergey Shulenin, Robert Unfer, Sven G Enterlein, Vu Truong-Le, David B Volkin, Sangeeta B Joshi, C Russell Middaugh.   

Abstract

The filoviruses, Ebola virus and Marburg virus, cause severe hemorrhagic fever with up to 90% human mortality. Virus-like particles of EBOV (eVLPs) and MARV (mVLPs) are attractive vaccine candidates. For the development of stable vaccines, the conformational stability of these two enveloped VLPs produced in insect cells was characterized by various spectroscopic techniques over a wide pH and temperature range. Temperature-induced aggregation of the VLPs at various pH values was monitored by light scattering. Temperature/pH empirical phase diagrams (EPDs) of the two VLPs were constructed to summarize the large volume of data generated. The EPDs show that both VLPs lose their conformational integrity above about 50°C-60°C, depending on solution pH. The VLPs were maximally thermal stable in solution at pH 7-8, with a significant reduction in stability at pH 5 and 6. They were much less stable in solution at pH 3-4 due to increased susceptibility of the VLPs to aggregation. The characterization data and conformational stability profiles from these studies provide a basis for selection of optimized solution conditions for further vaccine formulation and long-term stability studies of eVLPs and mVLPs.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21858822     DOI: 10.1002/jps.22724

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  8 in total

1.  Evaluation of lumazine synthase from Bacillus anthracis as a presentation platform for polyvalent antigen display.

Authors:  Yangjie Wei; Newton Wahome; Greta VanSlyke; Neal Whitaker; Prashant Kumar; Michael L Barta; Wendy L Picking; David B Volkin; Nicholas J Mantis; C Russell Middaugh
Journal:  Protein Sci       Date:  2017-09-13       Impact factor: 6.725

2.  Glassy-state stabilization of a dominant negative inhibitor anthrax vaccine containing aluminum hydroxide and glycopyranoside lipid A adjuvants.

Authors:  Kimberly J Hassett; David J Vance; Nishant K Jain; Neha Sahni; Lilia A Rabia; Megan C Cousins; Sangeeta Joshi; David B Volkin; C Russell Middaugh; Nicholas J Mantis; John F Carpenter; Theodore W Randolph
Journal:  J Pharm Sci       Date:  2015-01-11       Impact factor: 3.534

3.  A thermostable, chromatographically purified Ebola nano-VLP vaccine.

Authors:  John H Carra; Karen A O Martins; Rowena D Schokman; Camenzind G Robinson; Jesse T Steffens; Sina Bavari
Journal:  J Transl Med       Date:  2015-07-15       Impact factor: 5.531

4.  Escherichia coli-derived virus-like particles in vaccine development.

Authors:  Xiaofen Huang; Xin Wang; Jun Zhang; Ningshao Xia; Qinjian Zhao
Journal:  NPJ Vaccines       Date:  2017-02-09       Impact factor: 7.344

Review 5.  Turning up the heat on COVID-19: heat as a therapeutic intervention.

Authors:  Marc Cohen
Journal:  F1000Res       Date:  2020-04-24

6.  Process monitoring of virus-like particle reassembly by diafiltration with UV/Vis spectroscopy and light scattering.

Authors:  Matthias Rüdt; Philipp Vormittag; Nils Hillebrandt; Jürgen Hubbuch
Journal:  Biotechnol Bioeng       Date:  2019-02-20       Impact factor: 4.530

7.  Production of Ebola virus-like particles in Drosophila melanogaster Schneider 2 cells.

Authors:  Eun-Mee Park; Sun-Whan Park; Ye-Ji Lee; Won-Ja Lee; Wooyoung Choi
Journal:  J Virol Methods       Date:  2018-08-23       Impact factor: 2.014

8.  Reporter Assays for Ebola Virus Nucleoprotein Oligomerization, Virion-Like Particle Budding, and Minigenome Activity Reveal the Importance of Nucleoprotein Amino Acid Position 111.

Authors:  Aaron E Lin; William E Diehl; Yingyun Cai; Courtney L Finch; Chidiebere Akusobi; Robert N Kirchdoerfer; Laura Bollinger; Stephen F Schaffner; Elizabeth A Brown; Erica Ollmann Saphire; Kristian G Andersen; Jens H Kuhn; Jeremy Luban; Pardis C Sabeti
Journal:  Viruses       Date:  2020-01-15       Impact factor: 5.048

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.